# Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)

> **NCT00890994** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 200 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00890994
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-19
- **Primary completion:** 2014-11-14
- **Final completion:** 2016-11-14
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890994, "Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00890994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*